KMT Hepatech, Inc. Company Profile

05:06 EDT 20th April 2018 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

PhoenixBio invests in KMT Hepatech

KMT Hepatech has reached an agreement to join efforts with PhoenixBio. Together the companies will advance the use of the cDNA-uPA/SCID mouse model with highly humanized liver to support researchers a...

KMT Hepatech expands humanized liver model services

KMT Hepatech is expanding its services with the PXB-Mouse â a humanized liver chimeric mouse model for drug discovery and development â following a strategic investment from PhoenixBio late last yea...

KMT Hepatech Announces Strategic Investment From PhoenixBio

KMT Hepatech, Inc. (“KMT”) announced today that it has reached an agreement to join efforts with PhoenixBio Co., Ltd. (PhoenixBio). Together they will advance the use of the c...

KMT Hepatech Announces Expansion of Staff and Operations in Edmonton, AB, Canada

KMT Hepatech, Inc. (“KMT”), a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of th...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "KMT Hepatech, Inc." on BioPortfolio

We have published hundreds of KMT Hepatech, Inc. news stories on BioPortfolio along with dozens of KMT Hepatech, Inc. Clinical Trials and PubMed Articles about KMT Hepatech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KMT Hepatech, Inc. Companies in our database. You can also find out about relevant KMT Hepatech, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record